Disease & disorder

prostate neoplasm

MONDO:0021259

A neoplasm (disease) that involves the prostate gland.

Clinical trials62
Recruiting13
Drug concepts studied17
Synonyms15

Research intelligence

Directly mapped studies only · unique clinical trials

Current registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.

Medications under investigation

Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.

Loading mapped interventions…

MONDO disease family

Loading verified ontology relationships…

Recruiting studies by city

Loading research-site locations…

Trial status

Loading…

Trial phase

Loading…

Study start year

Loading…

Investigated drug interventions

Loading…
Background context

prostate neoplasm

Wikidata Q56014511 ↗
Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

40 shown
Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation TherapyNCT06957691 · 2026-01-14
RECRUITING
A Study of LY4257496 in Participants With Cancer (OMNIRAY)NCT07114601 · 2025-08-06
RECRUITING
Robotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) TrialNCT06915909 · 2025-04-22
RECRUITING
Impact of Using the Airseal System With Ultra-low Pneumoperitoneum in Patients Undergoing Robot-assisted Radical Prostatectomy: A Prospective, Comparative, Randomized Clinical Study.NCT06784986 · 2025-02-01
RECRUITING
Prospective Study of Ultrahypofractionated Proton Beam Therapy for Localized Prostate CancerNCT07699705 · 2024-11-04
RECRUITING
Evaluating the Impact of Financial Navigation on Financial Catastrophe and Distress for Cancer CareNCT06630962 · 2024-07-15
RECRUITING
Effectiveness of Focal Therapy in Men With Prostate CancerNCT06223295 · 2024-02-01
RECRUITING
MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted BiopsyNCT05710380 · 2023-04-26
RECRUITING
Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer ProgressionNCT06292897 · 2023-03-20
RECRUITING
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.NCT05422911 · 2022-08-31
RECRUITING
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyNCT04075305 · 2019-02-01
RECRUITING
Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate BrachytherapyNCT03424850 · 2018-02-27
RECRUITING
Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion and Non-Contrast MRINCT06315595 · 2015-09-30
RECRUITING
Application of Quantum Detection-Driven Artificial Intelligence Algorithms for Single-Molecule cfDNA Characterization in the Early Diagnosis of Prostate CancerNCT07238959 · 2025-12-01
NOT_YET_RECRUITING
Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET StudyNCT06430411 · 2024-05-31
NOT_YET_RECRUITING
Remimazolam Versus Propofol for General Anesthesia Induction in Patients on Renin-angiotensin System Blockers Undergoing Robot-assisted Laparoscopic ProstatectomyNCT06093971 · 2023-11-17
COMPLETED
Diagnostic Performance of 18F-PSMA-1007 PET/CT in Suspected Prostate Cancer PatientNCT05422105 · 2023-07-01
SUSPENDED
Protein Kinase A in Prostate Cancer Tissue.NCT05460312 · 2023-03-01
UNKNOWN
Decreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose.NCT05276492 · 2023-01-24
TERMINATED
Prospective Comparative Study for Patients With Biochemical Recurrence Prostate Cancer Detecting by 18F-JK-PSMA-7NCT05622162 · 2022-12-19
UNKNOWN
Addition of a Focal Boost in External Beam Radiotherapy for Locally Advanced Prostate Cancer by Online Adaptive MR-guided RadiotherapyNCT05373316 · 2022-12-01
NOT_YET_RECRUITING
Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPCNCT05191017 · 2022-09-01
WITHDRAWN
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid TumorsNCT05252390 · 2022-03-29
TERMINATED
Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab DeviceNCT06789224 · 2022-02-15
COMPLETED
Robotic-arm Assisted 68 Ga PSMA PET/CT Guided Prostate Biopsy Versus MR Directed Cognitive Fusion TRUS Guided Prostate Biopsy (PROBIOP)NCT05137561 · 2021-10-25
COMPLETED
Strength, Aging, and Memory in Prostate CancerNCT04852224 · 2021-10-01
COMPLETED
Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomyNCT04053842 · 2021-02-04
COMPLETED
Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid TumorsNCT04541225 · 2020-12-08
TERMINATED
Learning MRI and Histology Image Mappings for Cancer Diagnosis and Prognosis.NCT04792138 · 2020-10-23
UNKNOWN
The Robot-Assisted Laparoscopic Radical Prostatectomy Combined Anterior and Posterior ApproachNCT06020287 · 2020-09-01
COMPLETED
Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0NCT04045717 · 2020-04-10
ACTIVE_NOT_RECRUITING
Unfavorable MRI But Favorable 68Ga-PSMA PET/MRI for Primary Prostate Cancer DetectionNCT04124107 · 2019-12-01
UNKNOWN
Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate CancerNCT04030338 · 2019-07-19
ACTIVE_NOT_RECRUITING
A Study of the Drugs Talazoparib and Temozolomide in Prostate CancerNCT04019327 · 2019-07-11
TERMINATED
Characterize Tumor Hypoxia by Magnetic Resonance ImagingNCT03987568 · 2019-07-10
WITHDRAWN
MRI-targeted Biopsy of the Prostate: Software Versus Visual Registration in the Accuracy of Prostate Cancer DetectionNCT03819751 · 2019-03-18
UNKNOWN
Prostate Cancer Screening Trial Using ImagingNCT03702439 · 2018-10-10
COMPLETED
Targeted Biopsy or Standard Biopsy for Clinical Significant Prostate Cancer DetectionNCT03572946 · 2018-10-09
UNKNOWN
CyberKnife Dose Escalation Prostate Cancer TrialNCT03822494 · 2018-07-12
ACTIVE_NOT_RECRUITING
Lutetium-177-PSMA-617 in Low Volume Metastatic Prostate CancerNCT03828838 · 2018-07-01
COMPLETED

Leading sponsors

National Cancer Institute (NCI)4Nuvation Bio Inc.3Radboud University Medical Center3Seoul National University Hospital3The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School3Memorial Sloan Kettering Cancer Center2Universitaire Ziekenhuizen KU Leuven2University College, London2University of Chicago2Aarhus University Hospital1Brazilian Institute of Robotic Surgery1British Columbia Cancer Agency1Cambridge University Hospitals NHS Foundation Trust1Community Cancer Center, Normal, Illinois1Crozer-Keystone Health System1

Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.